Quest Laboratories Ltd is Rated Hold

Feb 08 2026 10:10 AM IST
share
Share Via
Quest Laboratories Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 27 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Quest Laboratories Ltd is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Quest Laboratories Ltd indicates a neutral stance for investors. It suggests that while the stock may not be an immediate buy opportunity, it is not advisable to sell at this juncture either. This rating reflects a balance between the company’s strengths and challenges, signalling that investors should monitor the stock closely for future developments before making significant portfolio changes.

Rating Update Context

On 27 January 2026, MarketsMOJO revised the rating for Quest Laboratories Ltd from 'Sell' to 'Hold', accompanied by a notable increase in the Mojo Score from 45 to 61 points. This change reflects an improved outlook based on a comprehensive evaluation of the company’s current standing. It is important to note that all financial data and performance indicators discussed below are as of 08 February 2026, ensuring that readers receive the most recent and relevant information.

Quality Assessment

As of 08 February 2026, Quest Laboratories Ltd holds an average quality grade. This suggests that the company maintains a stable operational framework but does not exhibit exceptional strengths in areas such as profitability, management efficiency, or competitive positioning. Investors should consider that while the company is not underperforming drastically, it also lacks standout qualities that might drive rapid growth or significant market outperformance in the near term.

Valuation Perspective

The valuation grade for Quest Laboratories Ltd is currently rated as very attractive. This indicates that the stock is trading at a price level that may offer value relative to its earnings, assets, or cash flow. For value-oriented investors, this presents a potential opportunity to acquire shares at a reasonable cost. However, the attractive valuation must be weighed against other factors such as financial trends and market conditions before making investment decisions.

Financial Trend Analysis

The company’s financial grade is flat, signalling a lack of significant growth or deterioration in key financial metrics. As of today, Quest Laboratories Ltd has not demonstrated strong upward momentum in revenue, earnings, or cash flow trends. This stagnation may reflect challenges in the pharmaceuticals and biotechnology sector or company-specific issues that are limiting expansion. Investors should be cautious and look for signs of improvement in upcoming quarters.

Technical Outlook

From a technical standpoint, the stock exhibits a mildly bullish grade. Recent price movements show some positive momentum, with a three-month return of +16.15% as of 08 February 2026. However, the stock has experienced volatility, including a one-year return of -31.09% and a year-to-date decline of -9.22%. This mixed technical picture suggests that while there is some buying interest, the stock remains susceptible to fluctuations and may require confirmation of sustained upward trends before attracting broader investor confidence.

Stock Performance Overview

Currently, Quest Laboratories Ltd is classified as a microcap stock within the Pharmaceuticals & Biotechnology sector. Its recent performance metrics as of 08 February 2026 are as follows: no change in the last trading day, a modest gain of +1.06% over the past week, a decline of -4.81% over the last month, and a near flat performance over six months at -0.05%. These figures highlight a stock that is experiencing short-term fluctuations but has not yet established a clear long-term trend.

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Implications for Investors

For investors, the 'Hold' rating on Quest Laboratories Ltd suggests a cautious approach. The stock’s very attractive valuation may entice value investors seeking entry points, but the flat financial trend and average quality grade imply that significant growth catalysts are currently limited. The mildly bullish technical signals offer some optimism, yet the recent negative returns over the year and year-to-date period highlight the need for careful monitoring.

Investors should consider maintaining existing positions while awaiting clearer signs of financial improvement or stronger technical momentum. New investors might prefer to observe upcoming quarterly results and sector developments before committing capital, given the mixed signals presented by the company’s current profile.

Sector and Market Context

Operating within the Pharmaceuticals & Biotechnology sector, Quest Laboratories Ltd faces a competitive and rapidly evolving landscape. The sector often experiences volatility due to regulatory changes, research outcomes, and market sentiment. As a microcap entity, the company may be more sensitive to market fluctuations and liquidity constraints compared to larger peers. This context reinforces the prudence of a 'Hold' rating, reflecting balanced risk and reward considerations.

Summary

In summary, Quest Laboratories Ltd’s current 'Hold' rating by MarketsMOJO, updated on 27 January 2026, is supported by an average quality grade, very attractive valuation, flat financial trend, and mildly bullish technical outlook. As of 08 February 2026, the stock presents a mixed picture that warrants a measured investment stance. Investors should weigh the company’s valuation appeal against its operational and financial challenges, keeping a close eye on future developments that could influence its trajectory.

Looking Ahead

Going forward, key factors to watch include quarterly earnings growth, improvements in operational efficiency, and sector-wide trends that may impact pharmaceuticals and biotechnology stocks. Additionally, technical indicators should be monitored for confirmation of sustained upward momentum. These elements will be critical in determining whether Quest Laboratories Ltd can transition from a 'Hold' to a more favourable rating in the future.

Conclusion

Ultimately, the 'Hold' rating serves as a prudent recommendation for investors to maintain their current positions without rushing into new commitments. It reflects a balanced assessment of Quest Laboratories Ltd’s current fundamentals and market conditions, encouraging vigilance and informed decision-making in a dynamic sector environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are Quest Laboratories Ltd latest results good or bad?
Feb 13 2026 08:32 PM IST
share
Share Via
Quest Laboratories Ltd is Rated Hold
Jan 28 2026 10:10 AM IST
share
Share Via
Why is Quest Laboratories Ltd falling/rising?
Jan 24 2026 01:01 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Sell
Jan 05 2026 10:15 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Sell
Dec 25 2025 12:58 PM IST
share
Share Via
Most Read
Has Hindustan Aeronautics Ltd declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via
Has Anantam Highways Trust declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via
Has MSTC Ltd declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via
Has Wonder Electricals Ltd declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via
Has Mobavenue AI Tech Ltd declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via
Has Bharat Forge Ltd. declared dividend?
Feb 13 2026 11:31 PM IST
share
Share Via